Back to search

United Kingdom· GB-APID-14113511000001104

Bicalutamide 50mg tablets

A bicalutamide product containing bicalutamide, registered in United Kingdom by Consilient Health Ltd. The same ATC class is registered in 18 of our 19 countries.

ATC L02BB03

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedBicalutamide 50mg tabletsATCL02BB03REGISTER NO.GB-APID-1411351100000…PACKS LISTED2CHECKEDSeptember 13, 2026

Where it is registered

Bicalutamide is registered in 18 of 19 countries.

Countries holding a registration under ATC L02BB03 (bicalutamide), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 11 of them publish a price we can compare per daily dose

Bicalutamide · ATC L02BB03

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of bicalutamide costs, country by country.

Normalised to the WHO defined daily dose (50 mg), the median price runs from $1.21 in Italy to $2.29 in Switzerland — a ×1.9 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Bicalutamide · price per daily dose (50 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.29
  • ES Spain$1.61
  • FR France$1.42
  • IT Italy$1.21
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Bicalutamide
Manufacturer
Consilient Health Ltd
Country
United Kingdom (GB)
ATC code
L02BB03
ATC class
Bicalutamide
Defined daily dose
50 mg, O
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 2

  • gtin
    5391512450595
  • gtin
    05391512450595

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

477 interactions on record for bicalutamide.

Graded by severity as the source publishes them — 82 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Bicalutamide · interactions on record

477 records

  • 82 severe
  • 302 moderate
  • 15 minor
  • 78 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • LonafarnibA16AX20severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Bicalutamide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bicalutamide products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Androbloc, Bicalutamid +pharma
  • Belgium · Bicalutamide Eg, Bicalutamide Sandoz
  • Bulgaria · Бикагратис, Бикалутамид Акорд
  • Cyprus · Bicalutamide Rafarm, Bikalen
  • Czechia · Bicaluplex, Bicalutanorm
  • Germany · Bicadex, Bicalut
  • Denmark · Bicalustad, Bicalutamid Bluefish
  • Estonia · Bicalutamide Accord, Bicalutamide Teva
  • Spain · Bicalutamida Accord, Bicalutamida Almus
  • Finland · Bicalutamid Orion, Bicalutamide Accord
  • France · Bicalutamide Accord, Bicalutamide Almus
  • Greece · Bicalut, Bicalutamide Rafarm
  • Croatia · Bicaprox, Bikalis
  • Hungary · Bicalutamide Pharmacenter, Bilutamid
  • Ireland · Bicalutamide Accord, Bicalutamide Fair-Med
  • Iceland · Bicalutamid Medical, Bicalutamide Accord
  • Italy · Bicalutamide Accord, Bicalutamide Ahcl
  • Lithuania · Bicalutamide Accord, Bicalutamide Teva
  • Luxembourg · Bicalutamide Eg, Bicalutamide Teva
  • Latvia · Bicalutamide Accord, Bicalutamide Teva
  • Malta · Bicalutamide Pharmacare
  • Netherlands · Bicalutamide Accord, Bicalutamide Aurobindo
  • Norway · Bicalutamide Accord, Bicalutamide Bluefish
  • Poland · Bicalutamide Accord, Binabic
  • Portugal · Bicalutamida Accord, Bicalutamida Aurobindo
  • Romania · Bicalutamida Accord, Bicalutamidă Accord
  • Sweden · Bicalustad, Bicalutamid Sandoz
  • Slovenia · Bikalutamid Accord, Bikalutamid Lek
  • Slovakia · Bicagelan, Bicalutamid Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/33254154-8ca8-4afa-9cf6-d82917be5851
GET /v1/drugs/33254154-8ca8-4afa-9cf6-d82917be5851?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "14113511000001104",
  "desc": "Bicalutamide 50mg tablets (Consilient Health Ltd)",
  "form": "Oral tablet",
  "vpid": "42033211000001108",
  "source": "dmd",
  "vtm_id": "774854005",
  "strength": "50 mg",
  "substance": "Bicalutamide",
  "ingredient": "Bicalutamide",
  "supplier_code": "10309611000001109"
}

See everything about bicalutamide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.